Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.

The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.

Nilsson IM, Lee JC, Bremell T, Rydén C, Tarkowski A.

Infect Immun. 1997 Oct;65(10):4216-21.

2.

Role of the staphylococcal accessory gene regulator (sar) in septic arthritis.

Nilsson IM, Bremell T, Rydén C, Cheung AL, Tarkowski A.

Infect Immun. 1996 Nov;64(11):4438-43.

3.

Virulence of a hemB mutant displaying the phenotype of a Staphylococcus aureus small colony variant in a murine model of septic arthritis.

Jonsson IM, von Eiff C, Proctor RA, Peters G, Rydén C, Tarkowski A.

Microb Pathog. 2003 Feb;34(2):73-9.

PMID:
12623275
4.

The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model.

Abdelnour A, Arvidson S, Bremell T, Rydén C, Tarkowski A.

Infect Immun. 1993 Sep;61(9):3879-85.

5.

TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus.

Hultgren O, Eugster HP, Sedgwick JD, Körner H, Tarkowski A.

J Immunol. 1998 Dec 1;161(11):5937-42.

6.

Ribonucleotide reductase class III, an essential enzyme for the anaerobic growth of Staphylococcus aureus, is a virulence determinant in septic arthritis.

Kirdis E, Jonsson IM, Kubica M, Potempa J, Josefsson E, Masalha M, Foster SJ, Tarkowski A.

Microb Pathog. 2007 Nov-Dec;43(5-6):179-88. Epub 2007 May 25.

PMID:
17606358
7.
8.
10.

Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death.

Palmqvist N, Foster T, Tarkowski A, Josefsson E.

Microb Pathog. 2002 Nov;33(5):239-49.

PMID:
12473438
11.

Role of fibrinogen-binding adhesin expression in septic arthritis and septicemia caused by Streptococcus agalactiae.

Jonsson IM, Pietrocola G, Speziale P, Verdrengh M, Tarkowski A.

J Infect Dis. 2005 Oct 15;192(8):1456-64. Epub 2005 Sep 12.

PMID:
16170765
12.

Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis.

Gjertsson I, Innocenti M, Matrisian LM, Tarkowski A.

Microb Pathog. 2005 Feb-Mar;38(2-3):97-105.

PMID:
15748811
13.
14.

Role of macrophages in Staphylococcus aureus-induced arthritis and sepsis.

Verdrengh M, Tarkowski A.

Arthritis Rheum. 2000 Oct;43(10):2276-82.

15.

Virulence potential of the staphylococcal adhesin CNA in experimental arthritis is determined by its affinity for collagen.

Xu Y, Rivas JM, Brown EL, Liang X, Höök M.

J Infect Dis. 2004 Jun 15;189(12):2323-33. Epub 2004 May 25.

PMID:
15181582
16.

The impact of substance P signalling on the development of experimental staphylococcal sepsis and arthritis.

Verdrengh M, Tarkowski A.

Scand J Immunol. 2008 Mar;67(3):253-9. doi: 10.1111/j.1365-3083.2007.02065.x. Epub 2008 Jan 22.

17.
18.
19.

Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis.

Guo Y, Li J, Hagström E, Ny T.

Arthritis Rheum. 2008 Mar;58(3):764-72. doi: 10.1002/art.23263.

20.

Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice.

Tuchscherr LP, Buzzola FR, Alvarez LP, Caccuri RL, Lee JC, Sordelli DO.

Infect Immun. 2005 Dec;73(12):7932-7.

Supplemental Content

Support Center